Rheumatoid arthritis: A significant but often underestimated risk factor for perioperative cardiac morbidity [10]

Anesthesiology

Volumn 103, Issue 4, 2005, Pages 910-911

  Galvin, Eilish M ^a   O'Donnell, Dermot ^b   Leonard, Irene E ^b  

^a BEAUMONT HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; MORPHINE SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; CARDIOVASCULAR RISK; CASE REPORT; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HEMODYNAMIC MONITORING; HIGH RISK PATIENT; HUMAN; LETTER; MORTALITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SURGICAL RISK; THROMBOSIS;

EID: 26244466022     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200510000-00047     Document Type: Letter

References (19)

1. Goodson N: Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol 2002; 14:115-20
2. del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44:2737-45
3. Allebeck P: Increased mortality in rheumatoid arthritis. Scand J Rheumatol 1982; 11:81-6
4. Mutru O, Laakso M, Isomaki H, Koota K: Ten year mortality and causes of death in patients with rheumatoid arthritis. BMJ (Clin Res Ed) 1985; 290:1797-9.
5. Watson DJ, Rhodes T, Guess HA: All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 2003; 30:1196-202
6. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC: Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107:1303-7
7. Myllykangas-Luosujarvi R, Aho K, Kautiainen H. Isomaki H: Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995; 22:1065-7
8. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-47
9. Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD: Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 2002; 1:338-47
10. McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD: Cardiovascular risk factors including thrombotic variables in a population with rheumatoid arthritis. Rheumatology (Oxford) 2001; 40:640-4
11. Takayanagi M, Haraoka H, Kikuchi H, Hirohata S: Myocardial infarction caused by rheumatoid vasculitis: Histological evidence of the involvement of T-lymphocytes. Rheumatol Int 2003; 23:315-8
12. Parry G, Goudevenos J, Williams DO: Coronary thrombosis postpartum in a young woman with Still's disease. Clin Cardiol 1992; 15:305-7
13. Bacon PA, Raza K, Banks MJ, Townend J, Kitas GD: The role of endothelial cell dysfunction in the cardiovascular mortality of RA. Int Rev Immunol 2002; 21:1-17
14. Fischer LM, Schlieriger RG, Matter C, Jick H, Meier CR: Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004; 93:198-200
15. Manzi S, Wasko MC: Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 2000; 59:321-5
16. Lagrand WK, Visser CA, Hermans WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE: C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation 1999; 100:96-102
17. Stern MP, Kolterman OG, Fries JF, McDevitt HO, Reaven GM: Adrenocortical steroid treatment of rheumatic diseases: Effects on lipid metabolism. Arch Intern Med 1973; 132:97-101
18. Roubenoff R, Dellaripa P, Nadeau MR, Abad LW, Muldoon BA, Selhub J, Rosenberg IH: Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 1997; 40:718-22
19. Haagsma CJ, Blom HJ, van Kiel PLCM: Influence of sulphsalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheumatic Dis 1999; 58:79-84